Abstract:To investigate the effect of ILC2s on Th2-type adaptive immunity during the acute exacerbation of chronic obstructive pulmonary disease (AECOPD), the study enrolled healthy people, stable COPD patients, and AECOPD patients. Flow cytometry was used to detect Th1, Th2, and ILC2 in the peripheral blood and CD80 and MHC II levels on ILC2. The mRNA levels of GATA3 , RORα , and CRTH2 of ILC2s were detected by RT-PCR. In addition, ILC2s from the peripheral blood of AECOPD patients were cocultured with CD4 + T cells from the peripheral blood of healthy controls. Cytokine levels in serum of the three groups and the in vitro coculture supernatants were measured by ELISA. Compared with the stable COPD group or the healthy control group, Th2 in the peripheral blood of AECOPD group increased dramatically, inducing an increase of Th2/Th1 ratio in AECOPD patients. Meanwhile, the level of IL-4 in the serum of this group was also increased. However, we also detected ILC2s in the peripheral blood of the AECOPD group and found that it was also increased, alone with the increased GATA3 , RORα , and CRTH2 mRNA levels. We also found that the CD80 and MHC II on ILC2 were significantly upregulated and the proportion of MHC II + ILC2 cells was significantly positively correlated with the proportion of Th2 cells in AECOPD patients. To further demonstrate the effect of ILC2 on Th2 cells, we cocultured ILC2 with CD4 + T cells in vitro, which also showed a significant increase of Th2 ratio as well as Th2-associated cytokines IL-4, IL-5, and IL-13. However, we found that this effect of ILC2s on Th2 cells could be inhibited by the addition of anti-MHC II. The Th2/Th1 balance shifts to Th2 in AECOPD. ILC2s may function as APC by the upregulation of MHC II and regulate adaptive immunity shift to Th2-type response in AECOPD.

Research Progress on Type Ⅱ Innate Lymphoid Cells in Chronic Obstructive Pulmonary Disease

Research progress on type Ⅱ innate lymphoid cells in respiratory mucosal immunity and lung diseases

The Origin and Role of Innate Lymphoid Cells in the Lung

Research Progress on the Role of Innate Lymphocytes in Chronic Obstructive Pulmonary Disease

[Research Progress on the Role of Type II Innate Lymphoid Cells in Liver Diseases].

Effect of Type 2 Innate Lymphoid Cells on T Cells and Its Role in Immunity Diseases

A crosstalk between type 2 innate lymphoid cells and alternative macrophages in lung development and lung diseases (Review)

[Type 2 Innate Lymphoid Cells and Chronic Rhinosinusitis].

Type 2 Innate Lymphoid Cells Participate in IL-33-stimulated Th2-associated Immune Response in Chronic Obstructive Pulmonary Disease

Modulating ILC2 function for treatment of type 2 airway diseases

The Role of Type 2 Innate Lymphoid Cells in Allergic Diseases

New insights into the function, development, and plasticity of type 2 innate lymphoid cells

Functions of Group 2 Innate Lymphoid Cells in Tumor Microenvironment

ILC2s Induce Adaptive Th2-Type Immunity in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Heterogeneity of Group 2 Innate Lymphoid Cells Defines Their Pleiotropic Roles in Cancer, Obesity, and Cardiovascular Diseases

ILC2s: Unraveling the Innate Immune Orchestrators in Allergic Inflammation

Guards at the gate: physiological and pathological roles of tissue-resident innate lymphoid cells in the lung

Maturation and specialization of group 2 innate lymphoid cells through the lung-gut axis

Interferons as negative regulators of ILC2s in allergic lung inflammation and respiratory viral infections

Research progress of group Ⅱ innate lymphoid cells in the allergic rhinitis

The production, function, and clinical applications of IL-33 in type 2 inflammation-related respiratory diseases